| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Date of Report (Date of earliest event reported): November 9, 2026 |
| 10 Nov 2026 |
Form 4: Browers Blaine, CHIEF FINANCIAL OFFICER
Received 150,000 shares by exercise or conversion · Gave up 59,025 shares to cover exercise price or tax ($1.92M) |
| 10 Nov 2026 |
Form 4: Williams Brad, PRESIDENT
Received 200,000 shares by exercise or conversion · Gave up 78,700 shares to cover exercise price or tax ($2.57M) |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
Grew Quarterly Net Sales 30% and Net Income 46% Year-Over-Year |
| 30 Sep 2026 | SCHEDULE 13D/A |
| 26 Aug 2026 |
Form 4: Kanders Warren B, Director
Sold 65,431 shares ($2.17M) · Sold 34,569 shares ($1.16M) · Sold 100,000 shares ($3.19M) |
| 25 Aug 2026 | 144 |
| 24 Aug 2026 | 144 |
| 19 Aug 2026 |
Form 4: Williams Brad, PRESIDENT
Received 42,770 shares by exercise or conversion ($1M) · Received 45,972 shares by exercise or conversion ($944K) · Sold 88,742 shares ($2.95M) |
| 17 Aug 2026 | 144 |
| 07 Aug 2026 | EFFECT |
| 07 Aug 2026 |
8-K/A: Results of Operations and Financial Condition
Grew Quarterly Net Sales 32% and Gross Profit 36% Year-Over-Year |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 | S-4/A |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
Grew Quarterly Net Sales 32% and Gross Profit 36% Year-Over-Year |
| 29 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
THIS AMENDED AND RESTATED LOAN AGREEMENT (the “Agreement”), is entered into as of July 23, 2026, among MED-ENG HOLDINGS ULC, an unlimited liability company organized under the laws of British Columbia (“Med-Eng”) with an address at 2400 ... |
| 23 Jun 2026 |
Form 4: Kanders Warren B, Director
Sold 25,000 shares ($697K) · Sold 50,000 shares ($1.37M) |
| 18 Jun 2026 |
Form 4: Kissel Mary E., Director
Granted 17,393 Stock Option (right to purchase) |
Loading...